热门资讯> 正文
    
 AVTX、WISA和HTLD均为上市前涨幅股
 
        2024-04-16 20:45
      
  
 
 
  -  Gainers WiSA Technologies  (WISA) +64%.
  
  - Peraso  (PRSO) +51% Introduces New mmWave Wi-Fi Solution Utilizing Peraso's X710 Chipset Technology. 
  
  - Macatawa Bank  (MCBC) +39%.
  
  - BioRestorative Therapies  (BRTX) +25% Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment. 
  
  - Cullinan Oncology  (CGEM) +20% expands into autoimmune diseases. 
  
  - Intra-Cellular Therapies (ITCI) +20% Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder. 
  
  - ParaZero Technologies  (PRZO) +11%.
  
  - Enovix Corporation (ENVX) +9% completes Factory Acceptance Testing for its Gen2 Agility Line. 
  
  - Mobile-health Network Solutions (MNDR) +8%.
  
  - Avalo Therapeutics  (AVTX) +8%.
  
  - Unitedhealth Group  (UNH) +8%.
  
  - Telefonaktiebolaget L M Ericsson (ERIC) +8%.
  
  - Heartland Express (HTLD) +7%.
  
  - HNR Acquisition  (HNRA) +11%.
  
  - Agilon Health  (AGL) +7%.
  
  - Connexa Sports Technologies  (YYAI) +5%.
  
  - Mobilicom Limited (MOB) +6%.
  
  - Oncocyte Corporation (OCX) +5%.
  
 
 
  
  More on premarkets gainers and stock
 
   
   - WiSA Technologies to effect 1-for-150 reverse stock split
  
   - WiSA Technologies drops 5%, accepts Nasdaq compliance plan
  
   - Seeking Alpha’s Quant Rating on Avalo Therapeutics
  
   - Historical earnings data for Avalo Therapeutics
  
   - Financial information for Avalo Therapeutics
  
  
 
       
    风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。